Clinical Evaluation of Brain Death
Clinical Evaluation of Brain Death is divided into two main categories they are Prerequisites and Neurologic Assessment. Prerequisites: Brain death is the absence of clinical brain function when the proximate cause is known demonstrably irreversible. Clinical or neuroimaging evidence of an acute catastrophe that is compatible with the clinical diagnosis of brain death. No drug intoxication or poisoning. Neurologic Assessment: Coma, Absence of brainstem reflexes and apnea test.
Related Conference of Clinical Evaluation of Brain Death
Clinical Evaluation of Brain Death Conference Speakers
Recommended Sessions
- Anoxic Brain Injury
- Brain Death
- Brain Death and Disorders of consciousness
- Brain Death Causes
- Brain Death Diagnosis
- Brain Injury
- Brain Stem Stroke
- Brain Tumor
- Clinical Evaluation of Brain Death
- Coma vs. Brain Death
- Mental Illness
- Nursing and Intensive Care practices
- Organ Donation and Complications
- Pediatrics Brain Diseases
- Rehabilitation of Traumatic Brain Injury
Related Journals
Are you interested in
- Advanced Brain Death Imaging Techniques - BRAIN DEATH 2025 (France)
- Advocacy for Improved Care - BRAIN DEATH 2025 (France)
- AI and Machine Learning in Diagnosis - BRAIN DEATH 2025 (France)
- Behavioral Nutrition - PUBLIC HEALTH SUMMIT 2025 (USA)
- Childhood Obesity Prevention - PUBLIC HEALTH SUMMIT 2025 (USA)
- Collaborative Models of Brain Death Care - BRAIN DEATH 2025 (France)
- Community Health Programs - PUBLIC HEALTH SUMMIT 2025 (USA)
- Cultural Sensitivity in Care - BRAIN DEATH 2025 (France)
- Dietary Guidelines and Recommendations - PUBLIC HEALTH SUMMIT 2025 (USA)
- Ethics in Brain Death Diagnosis - BRAIN DEATH 2025 (France)
- Family-Centered Care Strategies - BRAIN DEATH 2025 (France)
- Food Marketing and Health - PUBLIC HEALTH SUMMIT 2025 (USA)
- Food Security and Sustainability - PUBLIC HEALTH SUMMIT 2025 (USA)
- Food Systems and Nutrition - PUBLIC HEALTH SUMMIT 2025 (USA)
- Global Health Initiatives - PUBLIC HEALTH SUMMIT 2025 (USA)
- Global Insights on Brain Death Care - BRAIN DEATH 2025 (France)
- Health Equity and Nutrition - PUBLIC HEALTH SUMMIT 2025 (USA)
- Innovative Neurocritical Care Approaches - BRAIN DEATH 2025 (France)
- Integrative Nutrition - PUBLIC HEALTH SUMMIT 2025 (USA)
- Legal Perspectives on Brain Death - BRAIN DEATH 2025 (France)
- Maternal and Infant Nutrition - PUBLIC HEALTH SUMMIT 2025 (USA)
- Micronutrient Deficiencies - PUBLIC HEALTH SUMMIT 2025 (USA)
- Neuroethics: End-of-Life Decisions - BRAIN DEATH 2025 (France)
- Neuromonitoring Innovations - BRAIN DEATH 2025 (France)
- Neurorehabilitation for Survivors - BRAIN DEATH 2025 (France)
- Neuroscience Revolution: Latest Breakthroughs - BRAIN DEATH 2025 (France)
- Novel Therapies for Brain Death Patients - BRAIN DEATH 2025 (France)
- Nutrition and Chronic Disease - PUBLIC HEALTH SUMMIT 2025 (USA)
- Nutrition and Mental Health - PUBLIC HEALTH SUMMIT 2025 (USA)
- Nutritional Education - PUBLIC HEALTH SUMMIT 2025 (USA)
- Nutritional Epidemiology - PUBLIC HEALTH SUMMIT 2025 (USA)
- Nutritional Genomics - PUBLIC HEALTH SUMMIT 2025 (USA)
- Obesity and Public Health - PUBLIC HEALTH SUMMIT 2025 (USA)
- Organ Donation Challenges and Solutions - BRAIN DEATH 2025 (France)
- Palliative Care Strategies - BRAIN DEATH 2025 (France)
- Public Awareness Campaigns - BRAIN DEATH 2025 (France)
- Public Health Nutrition Policies - PUBLIC HEALTH SUMMIT 2025 (USA)
- Research Translation to Practice - BRAIN DEATH 2025 (France)
- Supporting Patients and Families - BRAIN DEATH 2025 (France)